母乳育児に関する DPP 実現可能性調査 - eMOMS 2.0
糖尿病予防プログラム母乳育児の実現可能性調査 - 母親のスケジュールの電子モニタリング 2.0
The purpose of this study is to investigate the impact of a comprehensive intervention that combines breastfeeding support with a diabetes prevention-based program (DPP) on postpartum weight retention and lactation duration among women with pre-pregnancy overweight or obesity. This intervention, named eMOMS, is delivered by a certified health coach via a mobile health (mHealth) application.
調査の概要
詳細な説明
This study is a randomized controlled trial designed to determine the feasibility and efficacy of a combined breastfeeding, diabetes prevention-based program (DPP) in a cohort of overweight or obese women to be followed during pregnancy through 3 months postpartum. The trial will have two study arms: DPP + breastfeeding (Tx1) and Usual Care (Tx2).
Aim 1: Measure weight loss and duration of lactation through 3 months postpartum among target population. To accomplish this, we will measure pre-pregnancy weight, weight at study entry, weight immediately prior to and after delivery, and weight at specific postpartum time points. Lactation and infant feeding practices will be measured at similar postpartum time points. Aim 2: Quantify interest in use of the DPP-lactation mobile health (mHealth) application among target population. To accomplish this, we will: (1) measure research engagement including rates of screening and recruitment among users, especially rural and racially/ethnically diverse women; and (2) evaluate intervention uptake, delivery, and adherence via tracking/measuring use of the mHealth app.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Kansas
-
Wichita、Kansas、アメリカ、67218
- Via Christi Maternal Fetal Medicine Clinic
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Pregnant
- In second trimester or early third trimester
- BMI >/= 25 and < 35
- At least 18 years old or older
- Able to read and understand English
- Able to learn and use a video platform
Exclusion Criteria:
- Complications related to pregnancy that require emergency care
- Thyroid disease
- Multiple gestation
- Substance abuse within last 3 years
- Assisted reproductive technology (ART)-related pregnancy
- Current smoker
- Prior bariatric surgery
- In weight-loss program within 3 months of conception
- BMI >/= 35
- Unable to attend intervention/ follow-up visits
- Unwilling to self-monitor data collection
- Unable to complete intervention
- Presence of any condition that limits walking
- Presence of any condition that limits following diet recommendations
- Pregnancies complicated with fetuses diagnosed with lethal malformations/conditions
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:DPP + Breastfeeding (Tx1)
Patients randomized to Tx1 will receive education in the Diabetes Prevention Program (DPP) and intensive breastfeeding education and support. Ante- and postpartum education includes access to the mHealth app and individualized 1-on-1 health coaching. Phase I is delivered antepartum and includes: four (4) 1-hour DPP-based educational sessions and six (6) 20-minute educational videos on lactation. Phase II is delivered postpartum and includes: in-hospital lactation support and two (2) 1-hour DPP-based educational sessions. Participants will continue to receive individualized 1-on-1 health coaching through 3 months postpartum. |
The intervention will be administered by professionally trained, certified health coaches. Phase I consists of four 1-hour DPP-based sessions to be completed during pregnancy. Each session will be pre-recorded and archived on a secure, private mHealth application. Participants will be asked to complete each session on their own time. A health coach will follow up weekly via phone to check on progress and will work with the participant 1-on-1, if needed. Phase I will be completed by week 36 of pregnancy. Prior to delivery, participants are invited to a virtual focus group about their experiences. Phase II consists of two 1-hour DPP-based sessions to be completed after delivery. Each session will be pre-recorded and archived on the same mHealth application. Participants will begin Phase II within 1 week of delivery with the same health coach. Phase II will be completed by week 12 postpartum. Upon completion, participants are invited to a virtual focus group about their experiences. Phase I also consists of six (6) breastfeeding videos that are pre-recorded into 15-20 minute sessions and will be available on the mHealth application. Participants will have access to the first 2 sessions by week 28 of pregnancy and need to complete the remaining 4 sessions by week 36 of pregnancy. Each session is taught by an International Board Certified Lactation Consultant (IBCLC). Participants will receive 1-on-1 lactation support by the same DPP health coach. The health coach is a professionally trained Certified Breastfeeding Specialist (CBS). She will assist participants with any questions related to lactation. If the health coach is unable to help with a specific issue, she will contact the IBCLC-of-record, who will provide assistance to the health coach only. If the health coach or IBCLC deems additional care necessary, the participant will be referred to their primary care physician. The IBCLC will not have direct contact with the study participants. Participants will receive regular prenatal care provided by their physician. At delivery, all participants will receive some type of lactation support in the hospital. |
|
プラセボコンパレーター:Usual Care
Usual care is described as obstetrical care that pregnant women with normal BMI receive and that is provided by their provider. There will not be any antepartum education or 1-on-1 health coaching. Postpartum education will only include usual care in-hospital lactation support. There will not be any other education nor 1-on-1 support. |
Participants will receive regular prenatal care provided by their physician. At delivery, all participants will receive some type of lactation support in the hospital. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Weight
時間枠:At baseline and at delivery through 3 months postpartum
|
The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms. |
At baseline and at delivery through 3 months postpartum
|
|
Maternal Weight
時間枠:At baseline and at delivery through 3 months postpartum
|
The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms. |
At baseline and at delivery through 3 months postpartum
|
|
Duration of Breastfeeding and Supplementation
時間枠:At day 3, week 6, and 3 months postpartum.
|
The study team measured duration of breastfeeding and supplementation at day 3 postpartum and at specific timepoints through 3 months postpartum. Breastfeeding is defined as the feeding of human milk. The definition of "Exclusive Breastfeeding" is aligned with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) and is as follows: the infant is fed only human milk and no other foods or fluids, not even water, except for oral rehydration solutions or drops/syrups of vitamins, minerals, or medicines. "Any Breastfeeding" is defined as the feeding of human milk supplemented with formula, water, etc. "Formula Only" is defined as the feeding of formula exclusively and no human milk. |
At day 3, week 6, and 3 months postpartum.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Enrollment
時間枠:This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.
|
To assess recruitment and enrollment rates, the study team tracked the number of potential participants contacted/screened versus the number of participants who were eligible to enroll and the number of participants who consented to enroll in the study. |
This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.
|
|
mHealth Application Engagement
時間枠:At 3 months postpartum.
|
To assess intervention uptake, the study team tracked the number of calls engaging with the mobile health app and with the health coach. |
At 3 months postpartum.
|
|
mHealth Application Engagement (2)
時間枠:At 3 months postpartum.
|
To assess intervention uptake, the study team tracked the amount of time spent engaging with the mobile health app and with the health coach. |
At 3 months postpartum.
|
|
mHealth Application Usage
時間枠:At 3 months postpartum.
|
To assess intervention usage, the study team tracked logged tasks into the mobile health app. |
At 3 months postpartum.
|
協力者と研究者
捜査官
- 主任研究者:Lisette Jacobson, PhD, MPA, MA、University of Kansas Medical Center
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。